Topics:

USPC2012

USPC2012

Spice, Bath Salts, and Salvia are emerging drugs of abuse, with patients increasingly turning to these agents. Since their legal status varies and they can be difficult to detect on standard drug tests, their popularity may be increasing.

Your patient walks in with signs of traumatic injury, or intellectual or developmental disability. What special considerations are necessary in assessing and treating this patient?

The demands on physicians keep growing—they are not only responsible for assessment, diagnosis, and treatment, they are subject to all manner of related administrative and practice responsibilities. It’s no wonder that they are too busy to step back and periodically assess themselves and what they are doing.

In this 2-part video, Steven King, MD discusses the various causes of cancer pain and then focuses on role that psychiatrists can play in helping patients cope.

Pharmacological and nonpharmacological strategies to treat and manage comorbid schizophrenia and addiction concern psychiatrists who are learning strategies to help improve functional outcomes.

There has been substantial interest lately on the early stages of schizophrenia and the effects of untreated psychosis. Clinical trials have focused on medications for first episode, assessments of adverse effects, and “care paths” for the early/prodromal stage of psychosis.

New treatment options for mood disorders are under investigation, including the novel class of glutamatergic drugs.

Pages

Subscribe to USPC2012 on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.